Literature DB >> 1322822

Incidence of gestational trophoblastic disease in Stockholm County, 1975-1988.

F Flam1, V Lundström-Lindstedt, L E Rutqvist.   

Abstract

An epidemiological study with the aim of establishing the incidence of hydatidiform mole, persistent trophoblastic disease and choriocarcinoma in Stockholm County was performed. Based on the regional cancer registry and hospital registers, the incidence for 1975-1988 was calculated for the number of deliveries as well as the total number of pregnancies. Of the molar pregnancies, 6% were treated with chemotherapy because of invasive mole or choriocarcinoma. Non-molar choriocarcinoma occurred in 1/33,717 deliveries. Difficulties in assessing the incidence of gestational trophoblastic disease are discussed.

Entities:  

Mesh：

Year:  1992        PMID： 1322822     DOI： 10.1007/bf00144796

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  7 in total

1.  THE POSSIBLE ETIOLOGIC FACTORS OF HYDATIDIFORM MOLE AND CHORIOCARCINOMA: PRELIMINARY REPORT.

Authors:  H T POEN; M DJOJOPRANOTO
Journal:  Am J Obstet Gynecol       Date:  1965-06-15       Impact factor: 8.661

2.  Clinical and pathologic aspects of hydatidiform mole.

Authors:  I REINER; C M DOUGHERTY
Journal:  Obstet Gynecol       Date:  1960-06       Impact factor: 7.661

3.  Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958-1965.

Authors:  N Ringertz
Journal:  Acta Obstet Gynecol Scand       Date:  1970       Impact factor: 3.636

4.  Postmolar trophoblastic disease: diagnosis, management, and prognosis.

Authors:  C P Morrow
Journal:  Clin Obstet Gynecol       Date:  1984-03       Impact factor: 2.190

5.  Gestational trophoblastic disease within an elective abortion population.

Authors:  B A Cohen; R T Burkman; N B Rosenshein; M F Atienza; T M King; T H Parmley
Journal:  Am J Obstet Gynecol       Date:  1979-10-15       Impact factor: 8.661

6.  An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.

Authors:  M Stone; K D Bagshawe
Journal:  Br J Obstet Gynaecol       Date:  1979-10

7.  Hydatidiform mole in England and Wales 1973-83.

Authors:  K D Bagshawe; J Dent; J Webb
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321
  7 in total
  2 in total

1.  Implementation and Monitoring of a Gestational Trophoblastic Disease Management Program in a Tertiary Hospital in Morocco: Opportunities and Challenges.

Authors:  Imane Khachani; Mohamed Hassan Alami; Rachid Bezad
Journal:  Obstet Gynecol Int       Date:  2017-04-16

2.  Decreasing incidence of registered hydatidiform moles in Denmark 1999-2014.

Authors:  Helle Lund; Mogens Vyberg; Helle Højmark Eriksen; Anni Grove; Annette Østergaard Jensen; Lone Sunde
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.